PubMed=11170126; DOI=10.1002/1097-0045(200101)46:1<2::AID-PROS1002>3.0.CO;2-5
Anidjar M., Villette J.-M., Devauchelle P., Delisle F., Cotard J.-P., Billotey C., Cochand-Priollet B., Copin H., Barnoux M., Triballeau S., Rain J.-D., Fiet J., Teillac P., Berthon P., Cussenot O.
In vivo model mimicking natural history of dog prostate cancer using DPC-1, a new canine prostate carcinoma cell line.
Prostate 46:2-10(2001)

Patent=US20030013191
Cussenot O., Villette J.-M.
Prostatic cell line and use thereof to obtain an established prostatic cancer in an animal.
Patent number US20030013191, 16-Jan-2003

PubMed=21882212; DOI=10.1002/pros.21479
Anidjar M., Scarlata E., Cury F.L., Rocha J., Hamel L., Luz M., Chevalier S.
Refining the orthotopic dog prostate cancer (DPC)-1 model to better bridge the gap between rodents and men.
Prostate 72:752-761(2012)

PubMed=26714499; DOI=10.1186/s13550-015-0155-6; PMCID=PMC4695479
Chevalier S., Moffett S., Turcotte E., Luz M., Chauvette L., Derbekyan V., Scarlata E., Zouanat F., Aprikian A.G., Anidjar M.
The dog prostate cancer (DPC-1) model: a reliable tool for molecular imaging of prostate tumors and metastases.
EJNMMI Res. 5:77.1-77.13(2015)